Indobufen
Systematic (IUPAC) name | |
---|---|
2-(4-(1-Oxoisoindolin-2-yl)phenyl)butanoic acid | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Identifiers | |
63610-08-2 | |
B01AC10 | |
PubChem | CID 107641 |
ChemSpider | 96823 |
UNII | 6T9949G4LZ |
KEGG | D07141 |
ChEMBL | CHEMBL1765292 |
Chemical data | |
Formula | C18H17NO3 |
295.333 g/mol | |
SMILES
| |
| |
(what is this?) (verify) |
Indobufen is a platelet aggregation inhibitor.[1] It acts as a reversible cyclooxygenase inhibitor.[2]
References
- ↑ The Merck Index, 12th Edition. 4991
- ↑ Eligini, Sonia; Violi, F; Banfi, C; Barbieri, SS; Brambilla, M; Saliola, M; Tremoli, E; Colli, S (2005). "Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism". Cardiovascular Research 69 (1): 218–226. doi:10.1016/j.cardiores.2005.07.013. PMID 16154551.
|